Discovery of novel inhibitors targeting enoyl–acyl carrier protein reductase in Plasmodium falciparum by structure-based virtual screening
- 6 July 2007
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 358 (3) , 686-691
- https://doi.org/10.1016/j.bbrc.2007.04.113
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- In silico identification of novel EGFR inhibitors with antiproliferative activity against cancer cellsBioorganic & Medicinal Chemistry Letters, 2006
- Synthesis, biological activity, and X-ray crystal structural analysis of diaryl ether inhibitors of malarial enoyl acyl carrier protein reductase. Part 1: 4′-Substituted triclosan derivativesBioorganic & Medicinal Chemistry Letters, 2005
- Representing Receptor Flexibility in Ligand Docking through Relevant Normal ModesJournal of the American Chemical Society, 2005
- Defining the role of PfCRT in Plasmodium falciparum chloroquine resistanceMolecular Microbiology, 2005
- Formulation and characterization of triclosan sub-micron emulsions and nanocapsulesJournal of Microencapsulation, 2004
- Predictions of protein flexibility: First‐order measuresProteins-Structure Function and Bioinformatics, 2004
- Structural Elucidation of the Specificity of the Antibacterial Agent Triclosan for Malarial Enoyl Acyl Carrier Protein ReductaseJournal of Biological Chemistry, 2002
- Crystal Structure and Function of the Isoniazid Target of Mycobacterium tuberculosisScience, 1995
- ICM—A new method for protein modeling and design: Applications to docking and structure prediction from the distorted native conformationJournal of Computational Chemistry, 1994
- inhA , a Gene Encoding a Target for Isoniazid and Ethionamide in Mycobacterium tuberculosisScience, 1994